IL6 and non-small cell lung carcinoma: To investigate the hypothesis that IL-6 contributes to TIMP-1-mediated chemoresistance in NSCLCs, we carried out an apoptosis rescue assay to determine if exogenous rhIL-6 or rhTIMP-1 could protect NSCLC cells from chemotherapy-induced apoptosis.